Interstitial MR lymphography using Gd-carrying liposomes

Acta Radiologica, Supplement

Volumn 38, Issue 412, 1997, Pages 51-55

  Misselwitz, B ^a   Sachse, A ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Experimental; Liposomes, gadobutrol; Lymphography, interstitial MR lymphography; MR imaging, contrast agents

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG CARRIER; GADOBUTROL; GADOLINIUM; LIPOSOME; ORGANOMETALLIC COMPOUND;

ANIMAL; ARTICLE; DRUG TOLERANCE; FEMALE; GUINEA PIG; HISTOLOGY; INSTRUMENTATION; LYMPH NODE; MALE; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; RABBIT; RAT; STATISTICS; TIME;

ANIMALS; CONTRAST MEDIA; DRUG CARRIERS; DRUG TOLERANCE; FEMALE; GADOLINIUM; GUINEA PIGS; LIPOSOMES; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MALE; ORGANOMETALLIC COMPOUNDS; RABBITS; RATS; TIME FACTORS;

EID: 0030630649     PISSN: 03655954     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. BALLARD B. E.: Biopharmaceutical considerations in subcutaneous and intramuscular drug administration. J. Pharm. Sci. 57 (1968), 357.
2. BENGELE H. H., PALMACCI S., ROGERS J. et al.: Biodistribution of an ultrasmall super-paramagnetic iron oxide colloid, BMS 80549, by different routes of administration. Magn. Reson. Imaging 12 (1994), 433.
3. MANGAT S. & PATEL H. M.: Lymph node localization of non-specific antibody-coated liposomes. Life Sci. 36 (1985), 1917.
4. MUHLER A., ZHANG X., WANG H. et al.: Investigation of mechanisms influencing the accumulation of ultrasmall superparamagnetic iron oxide particles in lymph nodes. Invest. Radiol. 30 (1995), 98.
5. SCHNEIDER T., SACHSE A., RÖSSLING G. et al.: Large-scale production of liposomes of defined size by a new continuous high pressure extrusion device. Drug. Dev. Indust. Pharm. 20 (1994), 2787.
6. TORCHILIN V. P., TRUBETSKOY V. S., MILSHTEYN A. M. et al.: Targeted delivery of diagnostic agents by surface-modified liposomes. J. Controlled Release 28 (1994), 45.
7. UNGER E., NEEDLEMAN P., CULLIS P. et al.: Gadolinium-DTPA liposomes as a potential MRI contrast agent. Work in progress. Invest. Radiol. 23 (1988), 928.
8. UNGER E. C., SHEN D. & FRITZ T. A.: Status of liposomes as MR contrast agents. J. Magn. Reson. Imaging 3 (1991), 195.
9. UNGER E., SHEN D., Wu G. et al.: Liposomes as MR contrast agents. Pros and cons. Magn. Reson. Med. 22 (1991), 304.
10. VOGLER H., PLATZEK J., SCHUHMANN-GIAMPIERI G. et al.: Preclinical evaluation of gadobutrol. A new, neutral, extracellular contrast agent for magnetic resonance imaging. Eur. J. Radiol. 21 (1995), 1.
11. WEISSLEDER R., BOGDANOV A. A. JR & PAPISOV M.: Drug targeting in magnetic resonance imaging. In: Handbook of targeted delivery of imaging agents, p. 133. Edited by V. P. Torchilin. CRC Press, Boca Raton 1995.
12. WITTE C. L., WILLIAMS W. H. & WITTE M. H.: Lymphatic imaging. Lymphology 26 (1993), 109.